This site is intended for healthcare professionals

Medical education
Specialty
News
Congresses

Search
Menu

Home
Medical education
Specialty
News
Congresses

Megakaryocyte is a bone marrow cell responsible for the production of blood platelets, cellular image, pink and purple

Home
/
Medical education
/
Antiplatelet therapy in ACS – Overview
/
Videos
/
Controversies on choice of P2Y12 inhibitor: Are th...

Controversies on choice of P2Y12 inhibitor: Are the recommendations justifiable?

Antiplatelet therapy in ACS – Overview

Antiplatelet therapy in ACS
ACS Patient Focus
Expert Opinion
ESC 2022 Highlights

Controversies on choice of P2Y12 inhibitor

Get closer to the conversations that matter in medicine

ABOUT US
MEDICAL EDUCATION
SPECIALTIES
CONGRESS & EVENTS
NEWS & INSIGHTS
FOR GRANT PROVIDERS

© Medthority 2025 | Medthority.com

Privacy policy
Contact us